Ovid Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY. 

CEO
Jeremy Max Levin
CEOJeremy Max Levin
Employees
23
Employees23
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
23
Employees23

OVID Key Statistics

Market cap
115.72M
Market cap115.72M
Price-Earnings ratio
-3.19
Price-Earnings ratio-3.19
Dividend yield
Dividend yield
Average volume
1.68M
Average volume1.68M
High today
$1.66
High today$1.66
Low today
$1.50
Low today$1.50
Open price
$1.52
Open price$1.52
Volume
3.22M
Volume3.22M
52 Week high
$2.01
52 Week high$2.01
52 Week low
$0.2425
52 Week low$0.2425

Stock Snapshot

The current Ovid Therapeutics(OVID) stock price is $1.62, with a market capitalization of 115.72M. The stock trades at a price-to-earnings (P/E) ratio of -3.19.

On 2025-11-27, Ovid Therapeutics(OVID) stock moved within a range of $1.50 to $1.66. With shares now at $1.62, the stock is trading +7.7% above its intraday low and -2.7% below the session's peak.

Trading volume for Ovid Therapeutics(OVID) stock has reached 3.22M, versus its average volume of 1.68M.

Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.

Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.

OVID News

Simply Wall St 11h
November 2025's Top Penny Stock Opportunities

As the U.S. stock market enjoys a promising streak with major indexes on track for their best week since June, investors are eyeing opportunities across various...

November 2025's Top Penny Stock Opportunities

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.